JARA SOUTHERLAND: Open Payments
NPI 1881167997 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$674 in 35 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $197 · 2025 $674
Food & beverage: $674
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $154 |
| Neurocrine BioSciences, Inc. | 4 | $90 |
| Lilly USA, LLC | 5 | $89 |
| Exact Sciences Corporation | 4 | $66 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Astellas Pharma US Inc | 2 | $47 |
| Amgen Inc. | 3 | $46 |
| PFIZER INC. | 2 | $45 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Eisai Inc. | 1 | $23 |
Products named: INGREZZA, MOUNJARO, Ozempic, The Cologuard Plus Collection Kit, Veozah, NURTEC ODT, EVENITY, JARDIANCE.
Industry payments across IN — which companies pay providers there.
